|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 48/00 | (2006.01) | ||
| A61K 31/7105 | (2006.01) | ||
| C07H 21/02 | (2006.01) |
| (11) | Number of the document | 3338765 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18156531.8 |
| Date of filing the European patent application | 2010-11-30 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation | 2019-06-25 |
| (30) | Number | Date | Country code |
| 265653 P | 2009-12-01 | US |
| (72) |
GUILD, Braydon, Charles, US
DEROSA, Frank, US
HEARTLEIN, Michael, US
CONCINO, Michael, US
|
| (73) |
Translate Bio, Inc.,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Steroidiniai dariniai, skirti mRNR tiekimui, esant genetinėms ligoms |
| STEROID DERIVATIVE FOR THE DELIVERY OF MRNA IN HUMAN GENETIC DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-10-23 | 16 | 347.00 EUR |
| 2026-11-30 |